Velarion · Company Intelligence
Compensation Brief
Fiscal year 2024 · Filings through 2026-07-22

Merus (MRUS)

CEO Sven (Bill) Ante Lundberg was paid $9,643,774 in fiscal year 2024, ↑ up 106.4% from fiscal year 2023, the 41st percentile of its disclosed peer group (SEC filing 0001193125-25-093505 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$9,643,774 ↑
Sven (Bill) Ante Lundberg total, FY2024
41st
CEO pay percentile vs peers
47:1
CEO-to-median pay ratio
99.63%
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Sven (Bill) Ante Lundberg (President, Chief Executive Officer), FY2024 total compensation $9,643,774 (base salary $676,000) [exec_comp, SEC accession 0001193125-25-093505, filed 2025-04-24]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

01

Summary Compensation Table — fiscal year 2024

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Sven (Bill) Ante Lundberg$676,000$0$0$8,403,120$527,280$0$37,374$9,643,774
President, Chief Executive Officer
Fabian Zohren251,500006,557,292129,27105,6596,943,722
Chief Medical Officer
Peter Silverman529,650002,504,597331,297034,2233,399,767
Chief Operating Officer and General Counsel
Greg Perry493,500002,504,597253,659010,3503,262,106
Chief Financial Officer
Andrew Joe246,376002,504,59700375,1593,126,132
Former Chief Medical Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2024 totalFY2023 totalFY2022 totalΔ FY2023→2024
Sven (Bill) Ante Lundberg$9,643,774$4,671,327$5,744,794↑ +4,972,447
Fabian Zohren6,943,722———
Peter Silverman3,399,7671,948,4821,968,197↑ +1,451,285
Greg Perry3,262,1066,207,522—↓ −2,945,416
Andrew Joe3,126,1321,664,3382,059,749↑ +1,461,794

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read Merus's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper MRUS reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

How we handle your data → Privacy

Companies that benchmark against MRUS
1 company names MRUS as a compensation peer

Each company listed discloses MRUS in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named MRUS in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2024 total
Anand MehraIndependent Director$472,201
Jason HaddockIndependent Director$640,098
Len KanavyIndependent Director$358,495
Mark IwickiIndependent Director$366,220
Maxine GowenIndependent Director$360,040
Paolo PucciIndependent Director$363,274
Victor SandorIndependent Director$371,807
02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2024 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Victor SandorDirector2025-05-22A13,193$0$0Derivative, Class A CommonForm 4 ↗
Paolo PucciDirector2025-05-22A13,19300Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-05-22A13,19300Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-05-22A13,19300Derivative, Class A CommonForm 4 ↗
Maxine GowenDirector2025-05-22A13,19300Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-05-22A13,19300Derivative, Class A CommonForm 4 ↗
Jason HaddockDirector2025-05-22A13,19300Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-06-20D34,00000Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-06-20D34,000531,793,840CommonForm 4 ↗
Peter SilvermanCOO & GC2025-06-20A34,00019632,740CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-09D6,69500Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-09D6,69555368,225CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-09A6,69519124,594CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-10D16,80500Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-10D16,80555924,275CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-10A16,80519312,741CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-17D25,000601,500,000CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-17D25,00000Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-17A25,00024610,750CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25A1,500——CommonForm 4 ↗
Dividend-equivalent accruals2025-11-25—6,100——1 insider, 5 accrual rows
Sven (Bill) Ante LundbergDirector2025-11-25A2,53900CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25D24,22900CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25D22,44900CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25D14,19800CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25D30,29700CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25D2,20000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25D8,30096796,136CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25A1,000——CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25A1,000——CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25A800——CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25D12,21500CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25A30,29700CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25A2,200——CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25A1,800——CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25A2,53900CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25A2,53900CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25A2,53800CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25D52,36900CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-26D1,70096163,370CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-26A8001914,888CommonForm 4 ↗
Dividend-equivalent accruals2025-11-26—1,700——1 insider, 2 accrual rows
Harry ShumanVP Controller, PAO2025-11-26A9002421,987CommonForm 4 ↗
Maxine GowenDirector2025-12-12D13,19300Derivative, Class A CommonForm 4 ↗
Paolo PucciDirector2025-12-12D6,12000Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D4,98300Derivative, Class A CommonForm 4 ↗
Maxine GowenDirector2025-12-12D8,84400Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D73,576977,136,872CommonForm 4 ↗
Paolo PucciDirector2025-12-12D17,26200Derivative, Class A CommonForm 4 ↗
Paolo PucciDirector2025-12-12D16,60400Derivative, Class A CommonForm 4 ↗
Paolo PucciDirector2025-12-12D13,19300Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D295,00000Derivative, Class A CommonForm 4 ↗
Fabian ZohrenChief Medical Officer2025-12-12D50,00000Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-12-12D8,63100Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-12-12D14,41400Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D8,50000Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D5,65000Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D8,63100Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D372,92400Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D100,00000Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D16,60400Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D6,12000Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D6,12000Derivative, Class A CommonForm 4 ↗
Dividend-equivalent accruals2025-12-12—1,200——1 insider, 2 accrual rows
Sven (Bill) Ante LundbergDirector2025-12-12D380,00000Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D360,00000Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D30,297972,938,809CommonForm 4 ↗
Fabian ZohrenChief Medical Officer2025-12-12D183,94300Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-12-12D104,00000Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-12-12D107,30000Derivative, Class A CommonForm 4 ↗
Jason HaddockDirector2025-12-12D13,19300Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-12-12D14,14900Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-12-12D16,60400Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D8,63100Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D14,41400Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D4,98300Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D17,00000Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D6,12000Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D16,60400Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D14,41400Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D107,30000Derivative, Class A CommonForm 4 ↗
Maxine GowenDirector2025-12-12D7,95700Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D4,98300Derivative, Class A CommonForm 4 ↗
Victor SandorDirector2025-12-12D6,12000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D11,002971,067,194CommonForm 4 ↗
Len KanavyDirector2025-12-12D8,50000Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-12-12D6,12000Derivative, Class A CommonForm 4 ↗
Maxine GowenDirector2025-12-12D16,60400Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D8,50000Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D5,65000Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D8,63100Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D16,60400Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D14,41400Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D8,84400Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D13,19300Derivative, Class A CommonForm 4 ↗
Victor SandorDirector2025-12-12D13,19300Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D27,55000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D23,42000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D5,00000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D4,70000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D16,00000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D7,60000Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D300,00000Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D351,62800Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D312,62000Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D9,19297891,624CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D9,19297891,624CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D9,19197891,527CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D9,19197891,527CommonForm 4 ↗
Peter SilvermanCOO & GC2025-12-12D83,00000Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-12-12D3,90000Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D16,372971,588,084CommonForm 4 ↗
Jason HaddockDirector2025-12-12D17,68800Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-12-12D20,00000Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-12-12D12,71400Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-12-12D125,00000Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-12-12D50,00000Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-12-12D7,66900Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-12-12D8,84400Derivative, Class A CommonForm 4 ↗
Victor SandorDirector2025-12-12D16,60400Derivative, Class A CommonForm 4 ↗
Victor SandorDirector2025-12-12D14,41400Derivative, Class A CommonForm 4 ↗
Victor SandorDirector2025-12-12D8,84400Derivative, Class A CommonForm 4 ↗
Victor SandorDirector2025-12-12D17,00000Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D5,65000Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D8,50000Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D13,19300Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D17,00000Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D8,84400Derivative, Class A CommonForm 4 ↗
Paolo PucciDirector2025-12-12D14,41400Derivative, Class A CommonForm 4 ↗
Paolo PucciDirector2025-12-12D8,84400Derivative, Class A CommonForm 4 ↗
Maxine GowenDirector2025-12-12D12,24000Derivative, Class A CommonForm 4 ↗
Maxine GowenDirector2025-12-12D14,41400Derivative, Class A CommonForm 4 ↗
Victor SandorDirector2025-12-12D8,63100Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-12-12D13,19300Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D14,50000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D12,40000Derivative, Class A CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

View all 142 transactions
InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Victor SandorDirector2025-05-22A13,193$0$0Derivative, Class A CommonForm 4 ↗
Paolo PucciDirector2025-05-22A13,19300Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-05-22A13,19300Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-05-22A13,19300Derivative, Class A CommonForm 4 ↗
Maxine GowenDirector2025-05-22A13,19300Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-05-22A13,19300Derivative, Class A CommonForm 4 ↗
Jason HaddockDirector2025-05-22A13,19300Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-06-20D34,00000Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-06-20D34,000531,793,840CommonForm 4 ↗
Peter SilvermanCOO & GC2025-06-20A34,00019632,740CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-09D6,69500Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-09D6,69555368,225CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-09A6,69519124,594CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-10D16,80500Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-10D16,80555924,275CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-10A16,80519312,741CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-17D25,000601,500,000CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-17D25,00000Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-07-17A25,00024610,750CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25A1,500——CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25D1,80000Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25A2,53900CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25D24,22900CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25D22,44900CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25D14,19800CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25D30,29700CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25D2,20000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25D8,30096796,136CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25A1,000——CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25A1,000——CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25A800——CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25D12,21500CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25A30,29700CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25D1,00000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25D1,00000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25D80000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25A2,200——CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25A1,800——CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25A2,53900CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25A2,53900CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25A2,53800CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-11-25D52,36900CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-25D1,50000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-26D1,70096163,370CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-26A8001914,888CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-26D90000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-26D80000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-11-26A9002421,987CommonForm 4 ↗
Maxine GowenDirector2025-12-12D13,19300Derivative, Class A CommonForm 4 ↗
Paolo PucciDirector2025-12-12D6,12000Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D4,98300Derivative, Class A CommonForm 4 ↗
Maxine GowenDirector2025-12-12D8,84400Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D73,576977,136,872CommonForm 4 ↗
Paolo PucciDirector2025-12-12D17,26200Derivative, Class A CommonForm 4 ↗
Paolo PucciDirector2025-12-12D16,60400Derivative, Class A CommonForm 4 ↗
Paolo PucciDirector2025-12-12D13,19300Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D295,00000Derivative, Class A CommonForm 4 ↗
Fabian ZohrenChief Medical Officer2025-12-12D50,00000Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-12-12D8,63100Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-12-12D14,41400Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D8,50000Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D5,65000Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D8,63100Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D372,92400Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D100,00000Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D16,60400Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D6,12000Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D6,12000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D50000Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D380,00000Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D360,00000Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D30,297972,938,809CommonForm 4 ↗
Fabian ZohrenChief Medical Officer2025-12-12D183,94300Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-12-12D104,00000Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-12-12D107,30000Derivative, Class A CommonForm 4 ↗
Jason HaddockDirector2025-12-12D13,19300Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-12-12D14,14900Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-12-12D16,60400Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D8,63100Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D14,41400Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D4,98300Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D17,00000Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D6,12000Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D16,60400Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D14,41400Derivative, Class A CommonForm 4 ↗
Greg PerryChief Financial Officer & PFO2025-12-12D107,30000Derivative, Class A CommonForm 4 ↗
Maxine GowenDirector2025-12-12D7,95700Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D4,98300Derivative, Class A CommonForm 4 ↗
Victor SandorDirector2025-12-12D6,12000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D11,002971,067,194CommonForm 4 ↗
Len KanavyDirector2025-12-12D8,50000Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-12-12D6,12000Derivative, Class A CommonForm 4 ↗
Maxine GowenDirector2025-12-12D16,60400Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D8,50000Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D5,65000Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D8,63100Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D16,60400Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D14,41400Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D8,84400Derivative, Class A CommonForm 4 ↗
Mark IwickiDirector2025-12-12D13,19300Derivative, Class A CommonForm 4 ↗
Victor SandorDirector2025-12-12D13,19300Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D27,55000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D70000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D23,42000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D5,00000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D4,70000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D16,00000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D7,60000Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D300,00000Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D351,62800Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D312,62000Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D9,19297891,624CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D9,19297891,624CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D9,19197891,527CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D9,19197891,527CommonForm 4 ↗
Peter SilvermanCOO & GC2025-12-12D83,00000Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-12-12D3,90000Derivative, Class A CommonForm 4 ↗
Sven (Bill) Ante LundbergDirector2025-12-12D16,372971,588,084CommonForm 4 ↗
Jason HaddockDirector2025-12-12D17,68800Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-12-12D20,00000Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-12-12D12,71400Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-12-12D125,00000Derivative, Class A CommonForm 4 ↗
Peter SilvermanCOO & GC2025-12-12D50,00000Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-12-12D7,66900Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-12-12D8,84400Derivative, Class A CommonForm 4 ↗
Victor SandorDirector2025-12-12D16,60400Derivative, Class A CommonForm 4 ↗
Victor SandorDirector2025-12-12D14,41400Derivative, Class A CommonForm 4 ↗
Victor SandorDirector2025-12-12D8,84400Derivative, Class A CommonForm 4 ↗
Victor SandorDirector2025-12-12D17,00000Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D5,65000Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D8,50000Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D13,19300Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D17,00000Derivative, Class A CommonForm 4 ↗
Anand MehraDirector2025-12-12D8,84400Derivative, Class A CommonForm 4 ↗
Paolo PucciDirector2025-12-12D14,41400Derivative, Class A CommonForm 4 ↗
Paolo PucciDirector2025-12-12D8,84400Derivative, Class A CommonForm 4 ↗
Maxine GowenDirector2025-12-12D12,24000Derivative, Class A CommonForm 4 ↗
Maxine GowenDirector2025-12-12D14,41400Derivative, Class A CommonForm 4 ↗
Victor SandorDirector2025-12-12D8,63100Derivative, Class A CommonForm 4 ↗
Len KanavyDirector2025-12-12D13,19300Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D14,50000Derivative, Class A CommonForm 4 ↗
Harry ShumanVP Controller, PAO2025-12-12D12,40000Derivative, Class A CommonForm 4 ↗
03

Grants of plan-based awards — fiscal year 2024

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Greg PerryOPTION2024-05-07——107,300—$2,504,597
Peter SilvermanOPTION2024-05-07——107,300—2,504,597
Sven (Bill) Ante LundbergOPTION2024-05-07——360,000—8,403,120
Fabian ZohrenOPTION2024-07-01——183,943—6,557,292
Andrew JoeOPTION2024-05-07——107,300—2,504,597
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Greg Perry$0$0$2,504,5970.0%
Peter Silverman002,504,5970.0%
Sven (Bill) Ante Lundberg008,403,1200.0%
Fabian Zohren006,557,2920.0%
Andrew Joe002,504,5970.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2024

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Greg PerryRSU139,846—$233,078
Sven (Bill) Ante LundbergOption7,66724.43—
Sven (Bill) Ante LundbergOption79,89624.61—
Peter SilvermanOption1,56324.43—
Peter SilvermanOption54,16716.07—
Fabian ZohrenOption183,94354.45—
Andrew JoeOption15,60513.77—
Andrew JoeOption104,00016.07—
Andrew JoeOption43,23024.61—
Peter SilvermanOption107,30036.06—
Greg PerryRSU4,983—8,305
Sven (Bill) Ante LundbergOption2,77036.09—
Greg PerryOption107,30036.09—
Sven (Bill) Ante LundbergOption197,91716.07—
Sven (Bill) Ante LundbergOption357,23036.09—
Peter SilvermanOption22,48024.61—
Peter SilvermanOption10,41715.87—
Andrew JoeOption20,31324.43—
05

Incentive-plan design — the Compensation Discussion & Analysis

We target the 50th percentile of the peer group, with variations as appropriate based on a unique combination of factors such as experience, performance, tenure, and criticality of role, among other relevant factors, with actual compensation received designed to reflect the combination of corporate and individual performance.

CEO STI target (% of salary)60%
CEO LTI target (% of salary)—
Independent consultantPearl Meyer
Clawback policyTrue
Anti-hedgingTrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20242024-05-0742,134,653154,9341,47099.63%Passed
20232023-05-2635,684,678408,195254,17798.87%Passed
20222022-05-3121,072,7355,161,8384,083,39780.32%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20242024-05-0799.63%a
20232023-05-2698.87%b
20222022-05-3180.32%c

a. Voting standard not stated in the filing.

b. Voting standard not stated in the filing.

c. Voting standard not stated in the filing.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)47 : 1
CEO total compensation—
Median employee compensation$204,923
08

Director compensation — fiscal year 2024

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Jason HaddockIndependent · Audit (Chair) · Newly elected$40,098$0$600,000——$640,098
Anand MehraIndependent · Nomination and Corporate Governance (Chair)172,2010300,000——472,201
Victor SandorIndependent58,4950300,000—13,312371,807
Mark IwickiIndependent · Compensation (Chair) · Nomination and Corporate Governance66,2200300,000——366,220
Paolo PucciIndependent · Audit · Compensation63,2740300,000——363,274
Maxine GowenIndependent · Audit60,0400300,000——360,040
Len KanavyIndependent · Audit · Nomination and Corporate Governance58,4950300,000——358,495
Sven (Bill) Ante LundbergEmployee director000—00
09

Board fee structure and ownership guideline

Annual cash retainer$43,045
Annual equity retainer$300,000
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)9,270 / 7,815 / 15,450
Stock ownership guideline—
09b

Total cost of the board

ComponentFY2024
Cash retainers and fees$518,823
Equity awards (grant-date value)$0
All other compensation$13,312
Total cost of the board$532,135

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2024

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies Merus names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Merus.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Immunovant, Inc.2026Eric Venker$636,618$0$19,010,639$0$20,158,767
2Madrigal Pharmaceuticals Inc.2025Bill Sibold918,53112,297,8504,537,1461,438,81419,206,341
3SpringWorks Therapeutics, Inc.2024Saqib Islam760,0007,899,7606,689,100798,00016,153,317
4Revolution Medicines, Inc.2025Mark Goldsmith812,5003,968,0768,995,114889,70014,672,390
5Biohaven Ltd.2025Vlad Coric920,4002,202,4809,900,043013,500,438
6ImmunityBio, Inc.2025Richard Adcock831,6672,787,8288,353,406485,16612,716,953
7Cytokinetics, Inc.2025Robert Blum853,0695,150,0195,095,918772,71511,881,456
8Crinetics Pharmaceuticals, Inc.2025R. Scott Struthers718,5003,280,5407,160,564462,35511,628,959
9Krystal Biotech, Inc.2025Krish Krishnan846,1674,104,8254,675,093010,442,485
10Arcus Biosciences, Inc.2025Terry Rosen775,0002,199,4506,008,860658,7509,656,813
11Merus2024Sven (Bill) Ante Lundberg676,00008,403,120527,2809,643,774
12IDEAYA Biosciences, Inc.2025Yujiro Hata700,00008,418,840378,0009,512,640
13Arrowhead Pharmaceuticals, Inc.2025Christopher Anzalone981,0466,810,29201,236,0009,029,861
14Syndax Pharmaceuticals, Inc.2025Michael Metzger754,3002,021,9653,454,360848,5887,089,213
15Arvinas, Inc.2025John Houston706,2362,685,8402,671,051457,0006,534,127
16Celldex Therapeutics, Inc.2025Anthony Marucci785,80404,027,59005,366,709
17Recursion Pharmaceuticals, Inc.2025Najat Khan600,0001,944,5472,501,058256,7775,349,065
18Iovance Biotherapeutics, Inc.2025Frederick Vogt800,000759,3750312,0001,888,175

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Merus130%Options 100not disclosedPearl Meyer
Arcus Biosciences, Inc.100%Options 67 · RSU 33not disclosedRadford
Arrowhead Pharmaceuticals, Inc.125%PSU 70 · RSU 30not disclosedCompensia
Arvinas, Inc.108%Options 50 · RSU 50not disclosedAon (Aon's Human Capital Solutions practice, a division of Aon plc)
Biohaven Ltd.not disclosednot disclosednot disclosedAon
Celldex Therapeutics, Inc.100%Options 100not disclosedAon (Human Capital Solutions practice, a division of Aon plc)
Crinetics Pharmaceuticals, Inc.not disclosedOptions 70 · RSU 30not disclosedPearl Meyer
Cytokinetics, Inc.120%RSU 50 · Options 50not disclosedAon Human Capital Solutions
IDEAYA Biosciences, Inc.90%Options 100not disclosedAon (Aon plc, Talent Solutions practice)
ImmunityBio, Inc.not disclosedOptions 75 · RSU 25not disclosedMercer
Immunovant, Inc.110%not disclosedNoCompensia
Iovance Biotherapeutics, Inc.60%not disclosedNoHaigh & Company
Krystal Biotech, Inc.100%not disclosednot disclosedCompensia, Inc.
Madrigal Pharmaceuticals Inc.195%PSU 33 · RSU 33 · Options 33Yes — Relative TSR vs Nasdaq Biotechnology IndexCompensia
Recursion Pharmaceuticals, Inc.80%RSU 50 · Option 50not disclosedCompensia
Revolution Medicines, Inc.146%Options 70 · RSU 30not disclosedCompensia
SpringWorks Therapeutics, Inc.140%not disclosedYes — Relative Total Shareholder Return (TSR)Aon
Syndax Pharmaceuticals, Inc.150%Options 34 · PSU 33 · RSU 33Yes — Company's three-year total shareholder return (TSR) as measured against the Nasdaq Biotechnology Index components TSRsAon

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

10d

Frequently asked questions

Who was the highest-paid executive at Merus in fiscal 2024?
As disclosed, Sven (Bill) Ante Lundberg (President, Chief Executive Officer) was the highest-paid executive at Merus in fiscal 2024, with total compensation of $9,643,774.
How does Merus's chief executive pay compare to its disclosed peer group?
As disclosed, Sven (Bill) Ante Lundberg's total compensation ranked at the 41st percentile of Merus's disclosed peer group.
What is Merus's CEO-to-median employee pay ratio?
As disclosed, Merus's CEO-to-median employee pay ratio was 47:1.
How did shareholders vote on Merus's executive compensation?
As disclosed, 99.63% of shareholders supported Merus's executive compensation in the latest say-on-pay vote.
How much does Merus spend in total on board compensation for fiscal 2024?
As disclosed, Merus reported total board compensation of $532,135 for fiscal 2024.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Sven (Bill) Ante LundbergDEF 14A2025-04-240001193125-25-093505Section “2024 SUMMARY COMPENSATION TABLE” · page 64. As printed: 9,643,774. Filing ↗machine: t179 · r3 · c27 · span 565357–565366
2Section 01, Fabian ZohrenDEF 14A2025-04-240001193125-25-093505Section “2024 SUMMARY COMPENSATION TABLE” · page 64. As printed: 6,943,722. Filing ↗machine: r15 · c27 · span 586310–586319
3Section 01, Peter SilvermanDEF 14A2025-04-240001193125-25-093505Section “2024 SUMMARY COMPENSATION TABLE” · page 64. As printed: 3,399,767. Filing ↗machine: t179 · r9 · c27 · span 576511–576520
4Section 01, Greg PerryDEF 14A2025-04-240001193125-25-093505Section “2024 SUMMARY COMPENSATION TABLE” · page 64. As printed: 3,262,106. Filing ↗machine: t179 · r6 · c27 · span 570189–570198
5Section 01, Andrew JoeDEF 14A2025-04-240001193125-25-093505Section “2024 SUMMARY COMPENSATION TABLE” · page 64. As printed: 3,126,132. Filing ↗machine: t179 · r12 · c27 · span 583103–583112
6Section 03, Greg Perry OPTIONDEF 14A2025-04-240001193125-25-093505Section “SUMMARY COMPENSATION TABLE &” · grants of plan-based awards table. Filing ↗machine: t179 · r6 · c15 · span 568411–568420
7Section 03, Peter Silverman OPTIONDEF 14A2025-04-240001193125-25-093505Section “SUMMARY COMPENSATION TABLE &” · grants of plan-based awards table. Filing ↗machine: t179 · r9 · c15 · span 573797–573806
8Section 03, Sven (Bill) Ante Lundberg OPTIONDEF 14A2025-04-240001193125-25-093505Section “SUMMARY COMPENSATION TABLE &” · grants of plan-based awards table. Filing ↗machine: t179 · r3 · c15 · span 562642–562651
9Section 03, Fabian Zohren OPTIONDEF 14A2025-04-240001193125-25-093505Section “SUMMARY COMPENSATION TABLE &” · grants of plan-based awards table. Filing ↗machine: t179 · r15 · c15 · span 585515–585524
10Section 03, Andrew Joe OPTIONDEF 14A2025-04-240001193125-25-093505Section “SUMMARY COMPENSATION TABLE &” · grants of plan-based awards table. Filing ↗machine: t179 · r12 · c15 · span 580389–580398
11Section 07, pay ratioDEF 14A—0001193125-25-093505Section “CEO Pay Ratio”. As printed: 47 : 1.machine: span 723924–723931
12Section 08, Jason HaddockDEF 14A2025-04-240001193125-25-093505Section “Director Compensation”. As printed: 640,098. Filing ↗machine: t202 · r4 · c15 · span 709977–709984
13Section 08, Anand MehraDEF 14A2025-04-240001193125-25-093505Section “Director Compensation”. As printed: 472,201. Filing ↗machine: t202 · r6 · c15 · span 712626–712633
14Section 08, Victor SandorDEF 14A2025-04-240001193125-25-093505Section “Director Compensation”. As printed: 371,807. Filing ↗machine: t202 · r8 · c15 · span 715280–715287
15Section 08, Mark IwickiDEF 14A2025-04-240001193125-25-093505Section “Director Compensation”. As printed: 366,220. Filing ↗machine: t202 · r2 · c15 · span 707324–707331
16Section 08, Paolo PucciDEF 14A2025-04-240001193125-25-093505Section “Director Compensation”. As printed: 363,274. Filing ↗machine: t202 · r7 · c15 · span 713935–713942
17Section 08, Maxine GowenDEF 14A2025-04-240001193125-25-093505Section “Director Compensation”. As printed: 360,040. Filing ↗machine: t202 · r3 · c15 · span 708641–708648
18Section 08, Len KanavyDEF 14A2025-04-240001193125-25-093505Section “Director Compensation”. As printed: 358,495. Filing ↗machine: t202 · r5 · c15 · span 711285–711292
19Section 08, Sven (Bill) Ante LundbergDEF 14A2025-04-240001193125-25-093505Section “Director Compensation”. As printed: 0. Filing ↗
20Section 02, Victor Sandor 2025-05-22Form 42025-05-270000950170-25-077384Insider equity transaction reported since the proxy statement. Filing ↗
21Section 02, Paolo Pucci 2025-05-22Form 42025-05-270000950170-25-077385Insider equity transaction reported since the proxy statement. Filing ↗
22Section 02, Mark Iwicki 2025-05-22Form 42025-05-270000950170-25-077380Insider equity transaction reported since the proxy statement. Filing ↗
23Section 02, Anand Mehra 2025-05-22Form 42025-05-270000950170-25-077383Insider equity transaction reported since the proxy statement. Filing ↗
24Section 02, Maxine Gowen 2025-05-22Form 42025-05-270000950170-25-077382Insider equity transaction reported since the proxy statement. Filing ↗
25Section 02, Len Kanavy 2025-05-22Form 42025-05-270000950170-25-077388Insider equity transaction reported since the proxy statement. Filing ↗
26Section 02, Jason Haddock 2025-05-22Form 42025-05-270000950170-25-077386Insider equity transaction reported since the proxy statement. Filing ↗
27Section 02, Peter Silverman 2025-06-20Form 42025-06-240000950170-25-089442Insider equity transaction reported since the proxy statement. Filing ↗
28Section 02, Peter Silverman 2025-06-20Form 42025-06-240000950170-25-089442Insider equity transaction reported since the proxy statement. Filing ↗
29Section 02, Peter Silverman 2025-06-20Form 42025-06-240000950170-25-089442Insider equity transaction reported since the proxy statement. Filing ↗
30Section 02, Peter Silverman 2025-07-09Form 42025-07-110000950170-25-095292Insider equity transaction reported since the proxy statement. Filing ↗
31Section 02, Peter Silverman 2025-07-09Form 42025-07-110000950170-25-095292Insider equity transaction reported since the proxy statement. Filing ↗
32Section 02, Peter Silverman 2025-07-09Form 42025-07-110000950170-25-095292Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, Peter Silverman 2025-07-10Form 42025-07-110000950170-25-095292Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, Peter Silverman 2025-07-10Form 42025-07-110000950170-25-095292Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, Peter Silverman 2025-07-10Form 42025-07-110000950170-25-095292Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, Peter Silverman 2025-07-17Form 42025-07-180000950170-25-096919Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Peter Silverman 2025-07-17Form 42025-07-180000950170-25-096919Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Peter Silverman 2025-07-17Form 42025-07-180000950170-25-096919Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, Harry Shuman 2025-11-25Form 42025-11-280001193125-25-302551Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, Harry Shuman 2025-11-25Form 42025-11-280001193125-25-302551Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, Sven (Bill) Ante Lundberg 2025-11-25Form 42025-11-280001193125-25-302579Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, Sven (Bill) Ante Lundberg 2025-11-25Form 42025-11-280001193125-25-302579Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Sven (Bill) Ante Lundberg 2025-11-25Form 42025-11-280001193125-25-302579Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Sven (Bill) Ante Lundberg 2025-11-25Form 42025-11-280001193125-25-302579Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Sven (Bill) Ante Lundberg 2025-11-25Form 42025-11-280001193125-25-302579Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Harry Shuman 2025-11-25Form 42025-11-280001193125-25-302551Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Harry Shuman 2025-11-25Form 42025-11-280001193125-25-302551Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Harry Shuman 2025-11-25Form 42025-11-280001193125-25-302551Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Harry Shuman 2025-11-25Form 42025-11-280001193125-25-302551Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, Harry Shuman 2025-11-25Form 42025-11-280001193125-25-302551Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, Sven (Bill) Ante Lundberg 2025-11-25Form 42025-11-280001193125-25-302579Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, Sven (Bill) Ante Lundberg 2025-11-25Form 42025-11-280001193125-25-302579Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, Harry Shuman 2025-11-25Form 42025-11-280001193125-25-302551Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, Harry Shuman 2025-11-25Form 42025-11-280001193125-25-302551Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Harry Shuman 2025-11-25Form 42025-11-280001193125-25-302551Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, Harry Shuman 2025-11-25Form 42025-11-280001193125-25-302551Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, Harry Shuman 2025-11-25Form 42025-11-280001193125-25-302551Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Sven (Bill) Ante Lundberg 2025-11-25Form 42025-11-280001193125-25-302579Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Sven (Bill) Ante Lundberg 2025-11-25Form 42025-11-280001193125-25-302579Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Sven (Bill) Ante Lundberg 2025-11-25Form 42025-11-280001193125-25-302579Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Sven (Bill) Ante Lundberg 2025-11-25Form 42025-11-280001193125-25-302579Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Harry Shuman 2025-11-25Form 42025-11-280001193125-25-302551Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Harry Shuman 2025-11-26Form 42025-12-100001193125-25-314468Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Harry Shuman 2025-11-26Form 42025-12-100001193125-25-314468Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Harry Shuman 2025-11-26Form 42025-12-100001193125-25-314468Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Harry Shuman 2025-11-26Form 42025-12-100001193125-25-314468Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Harry Shuman 2025-11-26Form 42025-12-100001193125-25-314468Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, Maxine Gowen 2025-12-12Form 42025-12-120001193125-25-317924Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Paolo Pucci 2025-12-12Form 42025-12-120001193125-25-317942Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Anand Mehra 2025-12-12Form 42025-12-120001193125-25-317964Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Maxine Gowen 2025-12-12Form 42025-12-120001193125-25-317924Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, Mark Iwicki 2025-12-12Form 42025-12-120001193125-25-317936Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, Paolo Pucci 2025-12-12Form 42025-12-120001193125-25-317942Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, Paolo Pucci 2025-12-12Form 42025-12-120001193125-25-317942Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, Paolo Pucci 2025-12-12Form 42025-12-120001193125-25-317942Insider equity transaction reported since the proxy statement. Filing ↗
76Section 02, Sven (Bill) Ante Lundberg 2025-12-12Form 42025-12-120001193125-25-317947Insider equity transaction reported since the proxy statement. Filing ↗
77Section 02, Fabian Zohren 2025-12-12Form 42025-12-120001193125-25-317951Insider equity transaction reported since the proxy statement. Filing ↗
78Section 02, Len Kanavy 2025-12-12Form 42025-12-120001193125-25-317963Insider equity transaction reported since the proxy statement. Filing ↗
79Section 02, Len Kanavy 2025-12-12Form 42025-12-120001193125-25-317963Insider equity transaction reported since the proxy statement. Filing ↗
80Section 02, Greg Perry 2025-12-12Form 42025-12-120001193125-25-317968Insider equity transaction reported since the proxy statement. Filing ↗
81Section 02, Greg Perry 2025-12-12Form 42025-12-120001193125-25-317968Insider equity transaction reported since the proxy statement. Filing ↗
82Section 02, Greg Perry 2025-12-12Form 42025-12-120001193125-25-317968Insider equity transaction reported since the proxy statement. Filing ↗
83Section 02, Greg Perry 2025-12-12Form 42025-12-120001193125-25-317968Insider equity transaction reported since the proxy statement. Filing ↗
84Section 02, Greg Perry 2025-12-12Form 42025-12-120001193125-25-317968Insider equity transaction reported since the proxy statement. Filing ↗
85Section 02, Anand Mehra 2025-12-12Form 42025-12-120001193125-25-317964Insider equity transaction reported since the proxy statement. Filing ↗
86Section 02, Anand Mehra 2025-12-12Form 42025-12-120001193125-25-317964Insider equity transaction reported since the proxy statement. Filing ↗
87Section 02, Mark Iwicki 2025-12-12Form 42025-12-120001193125-25-317936Insider equity transaction reported since the proxy statement. Filing ↗
88Section 02, Harry Shuman 2025-12-12Form 42025-12-120001193125-25-317941Insider equity transaction reported since the proxy statement. Filing ↗
89Section 02, Sven (Bill) Ante Lundberg 2025-12-12Form 42025-12-120001193125-25-317947Insider equity transaction reported since the proxy statement. Filing ↗
90Section 02, Sven (Bill) Ante Lundberg 2025-12-12Form 42025-12-120001193125-25-317947Insider equity transaction reported since the proxy statement. Filing ↗
91Section 02, Sven (Bill) Ante Lundberg 2025-12-12Form 42025-12-120001193125-25-317947Insider equity transaction reported since the proxy statement. Filing ↗
92Section 02, Fabian Zohren 2025-12-12Form 42025-12-120001193125-25-317951Insider equity transaction reported since the proxy statement. Filing ↗
93Section 02, Peter Silverman 2025-12-12Form 42025-12-120001193125-25-317957Insider equity transaction reported since the proxy statement. Filing ↗
94Section 02, Peter Silverman 2025-12-12Form 42025-12-120001193125-25-317957Insider equity transaction reported since the proxy statement. Filing ↗
95Section 02, Jason Haddock 2025-12-12Form 42025-12-120001193125-25-317958Insider equity transaction reported since the proxy statement. Filing ↗
96Section 02, Len Kanavy 2025-12-12Form 42025-12-120001193125-25-317963Insider equity transaction reported since the proxy statement. Filing ↗
97Section 02, Len Kanavy 2025-12-12Form 42025-12-120001193125-25-317963Insider equity transaction reported since the proxy statement. Filing ↗
98Section 02, Anand Mehra 2025-12-12Form 42025-12-120001193125-25-317964Insider equity transaction reported since the proxy statement. Filing ↗
99Section 02, Anand Mehra 2025-12-12Form 42025-12-120001193125-25-317964Insider equity transaction reported since the proxy statement. Filing ↗
100Section 02, Greg Perry 2025-12-12Form 42025-12-120001193125-25-317968Insider equity transaction reported since the proxy statement. Filing ↗
101Section 02, Greg Perry 2025-12-12Form 42025-12-120001193125-25-317968Insider equity transaction reported since the proxy statement. Filing ↗
102Section 02, Greg Perry 2025-12-12Form 42025-12-120001193125-25-317968Insider equity transaction reported since the proxy statement. Filing ↗
103Section 02, Greg Perry 2025-12-12Form 42025-12-120001193125-25-317968Insider equity transaction reported since the proxy statement. Filing ↗
104Section 02, Greg Perry 2025-12-12Form 42025-12-120001193125-25-317968Insider equity transaction reported since the proxy statement. Filing ↗
105Section 02, Greg Perry 2025-12-12Form 42025-12-120001193125-25-317968Insider equity transaction reported since the proxy statement. Filing ↗
106Section 02, Maxine Gowen 2025-12-12Form 42025-12-120001193125-25-317924Insider equity transaction reported since the proxy statement. Filing ↗
107Section 02, Mark Iwicki 2025-12-12Form 42025-12-120001193125-25-317936Insider equity transaction reported since the proxy statement. Filing ↗
108Section 02, Victor Sandor 2025-12-12Form 42025-12-120001193125-25-317939Insider equity transaction reported since the proxy statement. Filing ↗
109Section 02, Harry Shuman 2025-12-12Form 42025-12-120001193125-25-317941Insider equity transaction reported since the proxy statement. Filing ↗
110Section 02, Len Kanavy 2025-12-12Form 42025-12-120001193125-25-317963Insider equity transaction reported since the proxy statement. Filing ↗
111Section 02, Len Kanavy 2025-12-12Form 42025-12-120001193125-25-317963Insider equity transaction reported since the proxy statement. Filing ↗
112Section 02, Maxine Gowen 2025-12-12Form 42025-12-120001193125-25-317924Insider equity transaction reported since the proxy statement. Filing ↗
113Section 02, Mark Iwicki 2025-12-12Form 42025-12-120001193125-25-317936Insider equity transaction reported since the proxy statement. Filing ↗
114Section 02, Mark Iwicki 2025-12-12Form 42025-12-120001193125-25-317936Insider equity transaction reported since the proxy statement. Filing ↗
115Section 02, Mark Iwicki 2025-12-12Form 42025-12-120001193125-25-317936Insider equity transaction reported since the proxy statement. Filing ↗
116Section 02, Mark Iwicki 2025-12-12Form 42025-12-120001193125-25-317936Insider equity transaction reported since the proxy statement. Filing ↗
117Section 02, Mark Iwicki 2025-12-12Form 42025-12-120001193125-25-317936Insider equity transaction reported since the proxy statement. Filing ↗
118Section 02, Mark Iwicki 2025-12-12Form 42025-12-120001193125-25-317936Insider equity transaction reported since the proxy statement. Filing ↗
119Section 02, Mark Iwicki 2025-12-12Form 42025-12-120001193125-25-317936Insider equity transaction reported since the proxy statement. Filing ↗
120Section 02, Victor Sandor 2025-12-12Form 42025-12-120001193125-25-317939Insider equity transaction reported since the proxy statement. Filing ↗
121Section 02, Harry Shuman 2025-12-12Form 42025-12-120001193125-25-317941Insider equity transaction reported since the proxy statement. Filing ↗
122Section 02, Harry Shuman 2025-12-12Form 42025-12-120001193125-25-317941Insider equity transaction reported since the proxy statement. Filing ↗
123Section 02, Harry Shuman 2025-12-12Form 42025-12-120001193125-25-317941Insider equity transaction reported since the proxy statement. Filing ↗
124Section 02, Harry Shuman 2025-12-12Form 42025-12-120001193125-25-317941Insider equity transaction reported since the proxy statement. Filing ↗
125Section 02, Harry Shuman 2025-12-12Form 42025-12-120001193125-25-317941Insider equity transaction reported since the proxy statement. Filing ↗
126Section 02, Harry Shuman 2025-12-12Form 42025-12-120001193125-25-317941Insider equity transaction reported since the proxy statement. Filing ↗
127Section 02, Harry Shuman 2025-12-12Form 42025-12-120001193125-25-317941Insider equity transaction reported since the proxy statement. Filing ↗
128Section 02, Sven (Bill) Ante Lundberg 2025-12-12Form 42025-12-120001193125-25-317947Insider equity transaction reported since the proxy statement. Filing ↗
129Section 02, Sven (Bill) Ante Lundberg 2025-12-12Form 42025-12-120001193125-25-317947Insider equity transaction reported since the proxy statement. Filing ↗
130Section 02, Sven (Bill) Ante Lundberg 2025-12-12Form 42025-12-120001193125-25-317947Insider equity transaction reported since the proxy statement. Filing ↗
131Section 02, Sven (Bill) Ante Lundberg 2025-12-12Form 42025-12-120001193125-25-317947Insider equity transaction reported since the proxy statement. Filing ↗
132Section 02, Sven (Bill) Ante Lundberg 2025-12-12Form 42025-12-120001193125-25-317947Insider equity transaction reported since the proxy statement. Filing ↗
133Section 02, Sven (Bill) Ante Lundberg 2025-12-12Form 42025-12-120001193125-25-317947Insider equity transaction reported since the proxy statement. Filing ↗
134Section 02, Sven (Bill) Ante Lundberg 2025-12-12Form 42025-12-120001193125-25-317947Insider equity transaction reported since the proxy statement. Filing ↗
135Section 02, Peter Silverman 2025-12-12Form 42025-12-120001193125-25-317957Insider equity transaction reported since the proxy statement. Filing ↗
136Section 02, Peter Silverman 2025-12-12Form 42025-12-120001193125-25-317957Insider equity transaction reported since the proxy statement. Filing ↗
137Section 02, Sven (Bill) Ante Lundberg 2025-12-12Form 42025-12-120001193125-25-317947Insider equity transaction reported since the proxy statement. Filing ↗
138Section 02, Jason Haddock 2025-12-12Form 42025-12-120001193125-25-317958Insider equity transaction reported since the proxy statement. Filing ↗
139Section 02, Peter Silverman 2025-12-12Form 42025-12-120001193125-25-317957Insider equity transaction reported since the proxy statement. Filing ↗
140Section 02, Peter Silverman 2025-12-12Form 42025-12-120001193125-25-317957Insider equity transaction reported since the proxy statement. Filing ↗
141Section 02, Peter Silverman 2025-12-12Form 42025-12-120001193125-25-317957Insider equity transaction reported since the proxy statement. Filing ↗
142Section 02, Peter Silverman 2025-12-12Form 42025-12-120001193125-25-317957Insider equity transaction reported since the proxy statement. Filing ↗
143Section 02, Len Kanavy 2025-12-12Form 42025-12-120001193125-25-317963Insider equity transaction reported since the proxy statement. Filing ↗
144Section 02, Len Kanavy 2025-12-12Form 42025-12-120001193125-25-317963Insider equity transaction reported since the proxy statement. Filing ↗
145Section 02, Victor Sandor 2025-12-12Form 42025-12-120001193125-25-317939Insider equity transaction reported since the proxy statement. Filing ↗
146Section 02, Victor Sandor 2025-12-12Form 42025-12-120001193125-25-317939Insider equity transaction reported since the proxy statement. Filing ↗
147Section 02, Victor Sandor 2025-12-12Form 42025-12-120001193125-25-317939Insider equity transaction reported since the proxy statement. Filing ↗
148Section 02, Victor Sandor 2025-12-12Form 42025-12-120001193125-25-317939Insider equity transaction reported since the proxy statement. Filing ↗
149Section 02, Anand Mehra 2025-12-12Form 42025-12-120001193125-25-317964Insider equity transaction reported since the proxy statement. Filing ↗
150Section 02, Anand Mehra 2025-12-12Form 42025-12-120001193125-25-317964Insider equity transaction reported since the proxy statement. Filing ↗
151Section 02, Anand Mehra 2025-12-12Form 42025-12-120001193125-25-317964Insider equity transaction reported since the proxy statement. Filing ↗
152Section 02, Anand Mehra 2025-12-12Form 42025-12-120001193125-25-317964Insider equity transaction reported since the proxy statement. Filing ↗
153Section 02, Anand Mehra 2025-12-12Form 42025-12-120001193125-25-317964Insider equity transaction reported since the proxy statement. Filing ↗
154Section 02, Paolo Pucci 2025-12-12Form 42025-12-120001193125-25-317942Insider equity transaction reported since the proxy statement. Filing ↗
155Section 02, Paolo Pucci 2025-12-12Form 42025-12-120001193125-25-317942Insider equity transaction reported since the proxy statement. Filing ↗
156Section 02, Maxine Gowen 2025-12-12Form 42025-12-120001193125-25-317924Insider equity transaction reported since the proxy statement. Filing ↗
157Section 02, Maxine Gowen 2025-12-12Form 42025-12-120001193125-25-317924Insider equity transaction reported since the proxy statement. Filing ↗
158Section 02, Victor Sandor 2025-12-12Form 42025-12-120001193125-25-317939Insider equity transaction reported since the proxy statement. Filing ↗
159Section 02, Len Kanavy 2025-12-12Form 42025-12-120001193125-25-317963Insider equity transaction reported since the proxy statement. Filing ↗
160Section 02, Harry Shuman 2025-12-12Form 42025-12-120001193125-25-317941Insider equity transaction reported since the proxy statement. Filing ↗
161Section 02, Harry Shuman 2025-12-12Form 42025-12-120001193125-25-317941Insider equity transaction reported since the proxy statement. Filing ↗
162Section 06, 2024 voteForm 8-K2024-05-080001193125-24-133796Item 5.07 · say-on-pay result. As reported: 99.63% (votes for as printed: 42,134,653). Filing ↗
163Section 06, 2023 voteForm 8-K2023-05-300001193125-23-156007Item 5.07 · say-on-pay result. As reported: 98.87% (votes for as printed: 35,684,678). Filing ↗
164Section 06, 2022 voteForm 8-K2022-05-310001193125-22-164095Item 5.07 · say-on-pay result. As reported: 80.32%. Filing ↗
165Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
166Section 03b vehicle mix (computed)Computed——RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
167Section 09b board cost (computed)Computed——Cash 518,823 + equity 0 + all other 13,312 = 532,135, summed across the director compensation table rows.machine: formula: Σ = 532,135
168Immunovant, Inc., Section 10b CEO totalDEF 14A2026-07-220001764013-26-000092CEO total compensation as printed in Immunovant, Inc.'s own proxy. As printed: 20,158,767. Filing ↗machine: span 465716–465726
169Madrigal Pharmaceuticals Inc., Section 10b CEO totalDEF 14A2026-04-280001308179-26-000352CEO total compensation as printed in Madrigal Pharmaceuticals Inc.'s own proxy. As printed: 19,206,341. Filing ↗machine: r2 · c24 · span 791942–791952
170SpringWorks Therapeutics, Inc., Section 10b CEO totalDEF 14A2025-04-040001104659-25-032187CEO total compensation as printed in SpringWorks Therapeutics, Inc.'s own proxy. As printed: 16,153,317. Filing ↗machine: r1 · c47 · span 623184–623194
171Revolution Medicines, Inc., Section 10b CEO totalDEF 14A2026-04-270001193125-26-182453CEO total compensation as printed in Revolution Medicines, Inc.'s own proxy. As printed: 14,672,390. Filing ↗machine: r2 · c27 · span 382608–382618
172Biohaven Ltd., Section 10b CEO totalDEF 14A2026-03-130001935979-26-000028CEO total compensation as printed in Biohaven Ltd.'s own proxy. As printed: 13,500,438. Filing ↗machine: r3 · c21 · span 423429–423439
173ImmunityBio, Inc., Section 10b CEO totalDEF 14A2026-04-300001326110-26-000049CEO total compensation as printed in ImmunityBio, Inc.'s own proxy. As printed: 12,716,953. Filing ↗machine: t62 · r3 · c22 · span 544834–544844
174Cytokinetics, Inc., Section 10b CEO totalDEF 14A2026-04-170001140361-26-015364CEO total compensation as printed in Cytokinetics, Inc.'s own proxy. As printed: 11,881,456. Filing ↗machine: r2 · c25 · span 777093–777103
175Crinetics Pharmaceuticals, Inc., Section 10b CEO totalDEF 14A2026-04-290001658247-26-000030CEO total compensation as printed in Crinetics Pharmaceuticals, Inc.'s own proxy. As printed: 11,628,959. Filing ↗machine: r2 · c48 · span 589450–589460
176Krystal Biotech, Inc., Section 10b CEO totalDEF 14A2026-04-030001711279-26-000036CEO total compensation as printed in Krystal Biotech, Inc.'s own proxy. As printed: 10,442,485. Filing ↗machine: span 547434–547444
177Arcus Biosciences, Inc., Section 10b CEO totalDEF 14A2026-04-210001724521-26-000025CEO total compensation as printed in Arcus Biosciences, Inc.'s own proxy. As printed: 9,656,813. Filing ↗machine: r2 · c48 · span 403740–403749
178Merus (subject), Section 10b CEO totalDEF 14A2025-04-240001193125-25-093505CEO total compensation as printed in Merus's own proxy. As printed: 9,643,774. Filing ↗machine: t179 · r3 · c27 · span 565357–565366
179IDEAYA Biosciences, Inc., Section 10b CEO totalDEF 14A2026-04-290001193125-26-191501CEO total compensation as printed in IDEAYA Biosciences, Inc.'s own proxy. As printed: 9,512,640. Filing ↗machine: r2 · c14 · span 627310–627319
180Arrowhead Pharmaceuticals, Inc., Section 10b CEO totalDEF 14A2026-01-270000879407-26-000019CEO total compensation as printed in Arrowhead Pharmaceuticals, Inc.'s own proxy. As printed: 9,029,861. Filing ↗machine: span 692475–692484
181Syndax Pharmaceuticals, Inc., Section 10b CEO totalDEF 14A2026-04-300001193125-26-197859CEO total compensation as printed in Syndax Pharmaceuticals, Inc.'s own proxy. As printed: 7,089,213. Filing ↗machine: span 936322–936331
182Arvinas, Inc., Section 10b CEO totalDEF 14A2026-04-290001628280-26-028156CEO total compensation as printed in Arvinas, Inc.'s own proxy. As printed: 6,534,127. Filing ↗machine: t20 · r3 · c22 · span 471921–471930
183Celldex Therapeutics, Inc., Section 10b CEO totalDEF 14A2026-04-290001104659-26-050884CEO total compensation as printed in Celldex Therapeutics, Inc.'s own proxy. As printed: 5,366,709. Filing ↗machine: r1 · c54 · span 1024857–1024866
184Recursion Pharmaceuticals, Inc., Section 10b CEO totalDEF 14A2026-04-300001601830-26-000065CEO total compensation as printed in Recursion Pharmaceuticals, Inc.'s own proxy. As printed: 5,349,065. Filing ↗machine: r5 · c24 · span 551909–551918
185Iovance Biotherapeutics, Inc., Section 10b CEO totalDEF 14A2026-04-280001104659-26-050458CEO total compensation as printed in Iovance Biotherapeutics, Inc.'s own proxy. As printed: 1,888,175. Filing ↗machine: r6 · c16 · span 797910–797919
186Section 10a, Celldex Therapeutics, Inc. reciprocityDEF 14A—0001104659-26-050884Celldex Therapeutics, Inc.'s most recent proxy was read; its disclosed peer group does not include Merus. Filing ↗
187Section 10a, SpringWorks Therapeutics, Inc. reciprocityDEF 14A—0001104659-25-032187SpringWorks Therapeutics, Inc.'s most recent proxy was read; its disclosed peer group does not include Merus. Filing ↗
188Section 10a, Arrowhead Pharmaceuticals, Inc. reciprocityDEF 14A—0000879407-26-000019Arrowhead Pharmaceuticals, Inc.'s most recent proxy was read; its disclosed peer group does not include Merus. Filing ↗
189Section 10a, Krystal Biotech, Inc. reciprocityDEF 14A—0001711279-26-000036Krystal Biotech, Inc.'s most recent proxy was read; its disclosed peer group does not include Merus. Filing ↗
190Section 10a, Arvinas, Inc. reciprocityDEF 14A—0001628280-26-028156Arvinas, Inc.'s most recent proxy was read; its disclosed peer group does not include Merus. Filing ↗
191Section 10a, Madrigal Pharmaceuticals Inc. reciprocityDEF 14A—0001308179-26-000352Madrigal Pharmaceuticals Inc.'s most recent proxy was read; its disclosed peer group does not include Merus. Filing ↗
192Section 10a, ImmunityBio, Inc. reciprocityDEF 14A—0001326110-26-000049ImmunityBio, Inc.'s most recent proxy was read; its disclosed peer group does not include Merus. Filing ↗
193Section 10a, Immunovant, Inc. reciprocityDEF 14A—0001764013-26-000092Immunovant, Inc.'s most recent proxy was read; its disclosed peer group does not include Merus. Filing ↗
194Section 10a, Revolution Medicines, Inc. reciprocityDEF 14A—0001193125-26-182453Revolution Medicines, Inc.'s most recent proxy was read; its disclosed peer group does not include Merus. Filing ↗
195Section 10a, Syndax Pharmaceuticals, Inc. reciprocityDEF 14A—0001193125-26-197859Syndax Pharmaceuticals, Inc.'s most recent proxy was read; its disclosed peer group does not include Merus. Filing ↗
196Section 10a, Biohaven Ltd. reciprocityDEF 14A—0001935979-26-000028Biohaven Ltd.'s most recent proxy was read; its disclosed peer group does not include Merus. Filing ↗
197Section 10a, Crinetics Pharmaceuticals, Inc. reciprocityDEF 14A—0001658247-26-000030Crinetics Pharmaceuticals, Inc.'s most recent proxy was read; its disclosed peer group does not include Merus. Filing ↗
198Section 10a, Cytokinetics, Inc. reciprocityDEF 14A—0001140361-26-015364Cytokinetics, Inc.'s most recent proxy was read; its disclosed peer group does not include Merus. Filing ↗
199Section 10a, Iovance Biotherapeutics, Inc. reciprocityDEF 14A—0001104659-26-050458Iovance Biotherapeutics, Inc.'s most recent proxy was read; its disclosed peer group does not include Merus. Filing ↗
200Section 10a, IDEAYA Biosciences, Inc. reciprocityDEF 14A—0001193125-26-191501IDEAYA Biosciences, Inc.'s most recent proxy was read; its disclosed peer group does not include Merus. Filing ↗

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.